4/17
02:54 pm
tvgn
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
Medium
Report
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
4/15
02:03 pm
tvgn
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
Low
Report
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
4/14
01:53 pm
tvgn
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
Low
Report
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
4/9
02:45 pm
tvgn
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
Medium
Report
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
4/8
05:53 pm
tvgn
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
High
Report
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
4/7
03:58 pm
tvgn
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
Low
Report
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
3/26
03:12 pm
tvgn
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
Low
Report
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
3/25
01:11 pm
tvgn
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
Low
Report
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
4/17
04:15 pm
tvgn
Form 8-K Tevogen Bio Holdings For: Apr 17
Low
Report
Form 8-K Tevogen Bio Holdings For: Apr 17
4/2
05:20 pm
tvgn
Form 10-K Tevogen Bio Holdings For: Dec 31
Medium
Report
Form 10-K Tevogen Bio Holdings For: Dec 31
4/1
08:00 am
tvgn
Form NT 10-K Tevogen Bio Holdings For: Dec 31
Low
Report
Form NT 10-K Tevogen Bio Holdings For: Dec 31
3/14
09:03 pm
tvgn
Form 4 Tevogen Bio Holdings For: Mar 12 Filed by: Flomenberg Neal
Low
Report
Form 4 Tevogen Bio Holdings For: Mar 12 Filed by: Flomenberg Neal
3/11
08:52 pm
tvgn
Form 4 Tevogen Bio Holdings For: Mar 07 Filed by: Flomenberg Neal
Low
Report
Form 4 Tevogen Bio Holdings For: Mar 07 Filed by: Flomenberg Neal
3/6
09:42 pm
tvgn
Form 4 Tevogen Bio Holdings For: Mar 04 Filed by: Flomenberg Neal
Low
Report
Form 4 Tevogen Bio Holdings For: Mar 04 Filed by: Flomenberg Neal
1/28
05:09 pm
tvgn
Form 424B3 Tevogen Bio Holdings
Medium
Report
Form 424B3 Tevogen Bio Holdings
1/28
04:52 pm
tvgn
Form 8-K Tevogen Bio Holdings For: Jan 28
Medium
Report
Form 8-K Tevogen Bio Holdings For: Jan 28
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register